Takeda Pharmaceutical (TAK) Return on Equity [ROE] (2019 - 2026)
Takeda Pharmaceutical (TAK) recorded Return on Equity [ROE] of 1.22% in the quarter ended Jun 30, 2026, down 3.97 percentage points from 5.19% a year earlier and down 0.28 percentage points from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Takeda Pharmaceutical reported Return on Equity [ROE] of -2.13%, down 3.61 percentage points from the prior year.
- Annual Return on Equity [ROE] has declined for three straight years, with a five-year change of -9.82 percentage points (years ended Mar 2021 to Mar 2026).
- Across earlier years, Return on Equity [ROE] came in at 1.48% in the year ended Mar 31, 2025 (-0.57 pp), 2.05% in the year ended Mar 31, 2024 (-2.75 pp), 4.81% in the year ended Mar 31, 2023 (+0.68 pp) and 4.12% in the year ended Mar 31, 2022 (-3.56 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Return on Equity [ROE] in data going back to the quarter ended Mar 31, 2019.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 3.13 percentage points in the quarter ended Mar 31, 2022, against a drop of 4.98 percentage points in the quarter ended Jun 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 1.50% (quarter ended Mar 31, 2026), 1.52% (quarter ended Dec 31, 2025) and 5.14% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Takeda Pharmaceutical | 2.58 Bn | -23.92 Bn | 5.10 Bn | 1.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22% |
| Mar 31, 2026 | 1.50% |
| Dec 31, 2025 | 1.52% |
| Sep 30, 2025 | 5.14% |
| Jun 30, 2025 | 5.19% |
| Mar 31, 2025 | 4.59% |
| Jun 30, 2024 | 6.95% |
| Mar 31, 2024 | 7.36% |
| Dec 31, 2023 | 7.69% |
| Sep 30, 2023 | 8.58% |
| Jun 30, 2023 | 5.55% |
| Mar 31, 2023 | 6.31% |
| Dec 31, 2022 | 7.12% |
| Sep 30, 2022 | 7.60% |
| Jun 30, 2022 | 10.53% |
| Mar 31, 2022 | 10.73% |
| Jun 30, 2021 | 9.87% |
| Mar 31, 2021 | 7.60% |
| Dec 31, 2020 | 5.19% |
| Jun 30, 2020 | 3.36% |
API Access
Takeda Pharmaceutical Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();